Hemophagocytic syndrome with graft-versus-host disease after liver transplantation: The bone marrow as a not so quiet battlefield?
- PMID: 34453381
- DOI: 10.1111/ajt.16816
Hemophagocytic syndrome with graft-versus-host disease after liver transplantation: The bone marrow as a not so quiet battlefield?
Keywords: editorial/personal viewpoint; graft-versus-host disease (GVHD); liver disease; liver transplantation/hepatology.
Comment on
-
Graft-versus-host disease after liver transplantation is associated with bone marrow failure, hemophagocytosis, and DNMT3A mutations.Am J Transplant. 2021 Dec;21(12):3894-3906. doi: 10.1111/ajt.16635. Epub 2021 Jul 19. Am J Transplant. 2021. PMID: 33961341
References
REFERENCES
-
- Murali AR, Chandra S, Stewart Z, et al. Graft versus host disease after liver transplantation in adults: a case series, review of literature, and an approach to management. Transplant. 2016;100:2661-2670.
-
- Toubai T, Magenau J. Immunopathology and biology-based treatment of steroid-refractory graft-versus-host disease. Blood. 2020;136:429-440.
-
- Paczesny S. Post-haematopoietic cell transplantation outcomes: why ST2 became a ‘golden nugget’ biomarker. Br J Haematol. 2021;192:951-967.
-
- Newell LF, Dunlap J, Gatter K, et al. Graft-versus-host disease after liver transplantation is associated with bone marrow failure, hemophagocytosis, and DNMT3A mutations [published online ahead of print 2021]. Am J Transplant. 2021. doi:10.1111/ajt.16635
-
- Steensma DP. Clinical consequences of clonal hematopoiesis of indeterminate potential. Blood Adv. 2018;2:3404-3410.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical
